Expert Pitch
Wichita State University

National airline quality expert comments on potential impact of COVID-19 on air travel

2-Mar-2020 2:20 PM EST, by Wichita State University

Dean Headley, co-author of the national Airline Quality Rating from Wichita State University, says public concerns over COVID-19 will mostly negatively affect air travel internationally, but will certainly have some impact on domestic air travel as the virus spreads. 

“At this point, the biggest impact is on international travel,” said Headley. “Truth be told, there’s a silver lining for those travelers who continue to fly domestically. If the coronavirus results in a reduction in passengers flying commercially, airline performance will likely be better. History shows that fewer travelers helps the system perform better.  Of course, the downside for the airlines is they’ll lose money because fewer people are traveling.” 

Initially, Headley says the large US airports will likely be affected more than smaller regional airports because they handle most of the international traffic. The hub and spoke system of air travel also presents challenges to all airports in trying to contain the virus.

Leisure travelers are in the process of making their summer plans now, so depending on the spread of the virus domestically, there could be a reduction in leisure travel for the summer, according to Headley. “There’s a lot of complex issues, especially concerning human nature and what people are willing to do despite warnings in terms of air travel and the community spread of the virus,” said Headley.

Looking back, the events of 9/11 come to mind regarding when air travel was considered a risky choice.  At this point, Headley says the airline industry shouldn’t suffer as much from COVID-19 as it did following 9/11.

“It took a couple of years for domestic air travel to recover from 9/11,” said Headley. “The coronavirus is scary, but I don’t think it scares the public like 9/11 did. A lot will depend though on what shape the virus takes over the next few months. Airlines and consumers alike should learn from this and be better prepared for next year and the year after that. Unless the coronavirus becomes more widespread in this country, the impact isn’t going to be as serious as post 9/11.”

# # # # #

 

Wichita State is distinctive for opening pathways to applied learning, applied research and career opportunities, alongside unsurpassed classroom, laboratory and online education. The university's beautiful 330-acre main campus is a supportive, rapidly expanding learn-work-live-play environment, where students gain knowledge and credentials to prepare for fulfilling lives and careers. Students enjoy a wide selection of day, evening and summer courses in more than 200 areas of study at the main campus and other locations throughout the metro area and online. WSU's approximately 16,000 students come from every state in the U.S. and more than 100 other countries. Wichita State's Innovation Campus is an interconnected community of partnership buildings, laboratories and mixed-use areas where students, faculty, staff, entrepreneurs and businesses have access to the university's vast resources and technology. For more information, follow us on Twitter at www.twitter.com/wichitastate and Facebook at www.facebook.com/wichita.state.




Filters close

Showing results

1120 of 4578
Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.

Released: 15-Jan-2021 11:20 AM EST
Will Covid-19 kill the high street once and for all?
University of Sheffield

The shift to home working during Covid-19, or ‘Zoomshock’, threatens the survival of local goods and services provided in city centres and business parks

14-Jan-2021 5:00 PM EST
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
Association of American Cancer Institutes (AACI)

AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.

Released: 15-Jan-2021 8:55 AM EST
The First Dose of the Pfizer Vaccine Gives About 50% COVID Protection, Not 91% Claimed by Those Who Want to Speed Up Immunization
Newswise

The NEJM paper actually states that the efficacy between the first and second doses was found to be 52 percent when given 21 days apart. After the second dose, the efficacy raises to 95 percent.

Released: 15-Jan-2021 8:20 AM EST
Houston Methodist study finds males of all ages more affected by COVID-19 than females
Houston Methodist

A new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary journal published by the Public Library of Science.

Released: 15-Jan-2021 8:20 AM EST
NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19
Front Line COVID-19 Critical Care Alliance (FLCCC Alliance)

NIH Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19 Ivermectin is Now a Therapeutic Option for Doctors & Prescribers


Showing results

1120 of 4578

close
1.14261